High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.

Mauras, N; Attie, K M; Reiter, E O; Saenger, P; Baptista, J

Mauras, N; Attie, K M; Reiter, E O; Saenger, P; Baptista, J.

Affiliation

Mauras N; Nemours Children's Clinic and Research Programs, Jacksonville, Florida 32207, USA. nmauras@nemours.org

J Clin Endocrinol Metab ; 85(10): 3653-60, 2000 Oct.

Article in En | MEDLINE | ID: mdl-11061518

Subject(s)

Body Height/drug effects; Growth Hormone/therapeutic use; Human Growth Hormone/deficiency; Puberty/drug effects; Adolescent; Body Mass Index; Bone Density; Bone Development; Carbohydrate Metabolism; Child; Female; Growth/drug effects; Growth Hormone/administration & dosage; Growth Hormone/adverse effects; Humans; Insulin-Like Growth Factor I/metabolism; Male

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Body Height / Growth Hormone / Puberty / Human Growth Hormone Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: J Clin Endocrinol Metab Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links